期刊
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY
卷 4, 期 -, 页码 -出版社
AME PUBL CO
DOI: 10.21037/tgh.2019.05.10
关键词
Fecal microbiota transplantation (FMT); ulcerative colitis (UC); Crohn's disease (CD); microbiome
资金
- philanthropic funds from the Wagner Family led Gutsy Kids Fund
- Klaasmeyer family funds
In January of 2019, Samuel P. Costello and colleagues published a wonderfully executed, double blind placebo-controlled trial on fecal microbiota transplantation (FMT) versus autologous stool as placebo in mild to moderately active adult ulcerative colitis [UC: one type of inflammatory bowel disease (IBD)] patients. This review-commentary examines the current state of knowledge on human gut microbiome (live microbiota + their products and surrounding environment, i.e., fecal matter) and microbial therapeutics from a gastrointestinal (GI) clinician's standpoint. The varied forms of dysbiosis as the target of FMT, recipient donor and placebo considerations are also discussed in respect to randomized control trials in IBD [and the lack thereof in Crohn's disease (CD)] with this unconventional treatment modality.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据